المؤلفون: Rickard eMalmstrom, Brian eGodman, Eduardo eDiogene, Christoph eBaumgaertel, Marion eBennie, Iain eBishop, Anna eBrzezinska, Anna eBucsics, Stephen eCampbell, Alessandra eFerrario, Alexander eFinlayson, Jurij eFurst, Kristina eGaruoliene, Miguel eGomes, Iñaki eGutiérrez-Ibarluzea, Alan eHaycox, Krystyna eHviding, Harald eHerholz, Mikael eHoffmann, Saira eJan, Jan eJones, Roberta eJoppi, Marija eKalaba, Christina eKvalheim, Ott eLaius, Irene eLangner, Julie eLonsdale, Sven-Ake eLoov, Kamila eMalinowska, Laura eMcCullagh, Ken ePaterson, Vanda eMarkovic-Pekovic, Andrew eMartin, Jutta ePiessnegger, Gisbert eSelke, Catherine eSermet, Steven eSimoens, Faik Cankat Tulunay, Dominik eTomek, Luka eVoncina, Vera eVlahovic-Palcevski, Janet eWale, Michael eWilcock, Magda eWladysiuk, Menno van Woerkom, Corrine eZara, Lars L Gustafsson

المصدر: Frontiers in Pharmacology, Vol 4 (2013)

مصطلحات موضوعية: Registries, Pharmacovigilance, dabigatran, critical drug evaluation, demand-side measures, drug and therapeutics committees, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: http://journal.frontiersin.org/Journal/10.3389/fphar.2013.00039/full; https://doaj.org/toc/1663-9812

URL الوصول: https://doaj.org/article/ddc4fb6f64674453bbdb1706aa447bdf